OXAPEX
Live / Registered — Registered (as of 12 Jul 2022)
What this means for you
Registered since 12 Jul 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87780730
- Registration number
- 6784317
- Mark type
- Stylized text
- Filed
- 01 Feb 2018
- Published for opposition
- 26 Apr 2022
- Registered
- 12 Jul 2022
- Attorney of record
- Timothy T. Wang
Goods and services
- Class 005 — Pharmaceuticals: Human and veterinary pharmaceutical preparations for the prevention and treatment of cardiovascular disorders, tissue hypoxia, shock and anemia; Human and veterinary pharmaceutical preparations to increase plasma oxygen content; biological preparations for medical and veterinary purposes, namely, sterile solutions for use in oxygen therapeutics for the treatment of cardiovascular disorders, tissue hypoxia, shock, anemia, Gastrointestinal and Hepatobiliary System disease, Cardiovascular and Hematopoietic System diseases, Respiratory System diseases, Central Nervous System diseases, Musculo-Skeletal System diseases, Hormones related diseases, Oncology diseases, Genito-Urinary System diseases, Endocrine and Metabolic System diseases, Eye diseases, Ear and Mouth or Throat diseases, Skin diseases, Allergy and Immune System diseases; biological preparations for medical and veterinary purposes, namely, hemoglobin solution for pharmaceutical purpose and intravenous infusion solutions of a synthetic colloids and crystalloids all for the treatment of cardiovascular disorders, tissue hypoxia, shock, anemia, Gastrointestinal and Hepatobiliary System disease, Cardiovascular and Hematopoietic System diseases, Respiratory System diseases, Central Nervous System diseases, Musculo-Skeletal System diseases, Hormones related diseases, Oncology diseases, Genito-Urinary System diseases, Endocrine and Metabolic System diseases, Eye diseases, Ear and Mouth or Throat diseases, Skin diseases, Allergy and Immune System diseases; Biological preparations for medical and veterinary purposes, namely, protein arrays, biological tissue cultures, blood, blood plasma, and blood serums for the treatment of cardiovascular disorders, tissue hypoxia, shock, anemia, Gastrointestinal and Hepatobiliary System disease, Cardiovascular and Hematopoietic System diseases, Respiratory System diseases, Central Nervous System diseases, Musculo-Skeletal System diseases, Hormones related diseases, Oncology diseases, Genito-Urinary System diseases, Endocrine and Metabolic System diseases, Eye diseases, Ear and Mouth or Throat diseases, Skin diseases, Allergy and Immune System diseases
Owner
- FIRST GAIN INTERNATIONAL LIMITED, SHEUNG WAN, HK
- FIRST GAIN INTERNATIONAL LIMITED, SHEUNG WAN, HK
- FIRST GAIN INTERNATIONAL LIMITED, SHEUNG WAN, HK
- Hong Kong Cytogenetics and Medical Genetics Centre Limited, Hong Kong, HK
Prosecution history
- 12 Jul 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 12 Jul 2022 — REGISTERED-PRINCIPAL REGISTER
- 26 Apr 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Apr 2022 — PUBLISHED FOR OPPOSITION
- 06 Apr 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Mar 2022 — NOTICE OF ALLOWANCE CANCELLED
- 09 Mar 2022 — ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
- 09 Mar 2022 — PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
- 07 Mar 2022 — ASSIGNED TO PETITION STAFF
- 25 Feb 2022 — TEAS PETITION TO AMEND BASIS RECEIVED
- 18 Feb 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Feb 2022 — SOU EXTENSION 5 GRANTED
- 10 Feb 2022 — SOU EXTENSION 5 FILED
- 17 Feb 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 10 Feb 2022 — SOU TEAS EXTENSION RECEIVED